New drug duo aims to tame aggressive blood cancer
NCT ID NCT06252675
Summary
This study is testing whether combining two newer drugs, glofitamab and pirtobrutinib, is safe and effective for people with mantle cell lymphoma that has come back or stopped responding to previous treatments. The trial will enroll about 30 adults to see if this combination can help control the cancer and for how long. Researchers will closely monitor for side effects and measure how well the treatment works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MANTLE CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California, Davis
RECRUITINGDavis, California, 95616, United States
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94143, United States
Contact Email: •••••@•••••
Contact
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.